New Paper Published on Findings of RID Program’s COVERED Project
A new paper authored by the team behind the RID Program’s COVERED Project, which stands for The Canadian COVID-19 Vaccine Registry for Pregnant and Lactating Individuals has recently been published in the scientific journal Vaccine. This paper, which can be found here, is entitled “Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy […] Read More
RID Program Leader Dr. Deborah Money Honored with Woman’s Health Champion, Health Leader Award
Dr. Deborah Money, the leader of the RID program, professor of OB/GYN and clinician/scientist in Reproductive Infectious Diseases, was recently honored with the Women’s Health Champion, Health Leader Award at the annual Glow Gala hosted by the BC Women’s Health Foundation (BCWHF) and RBC. This award is given to a recipient each year by the […] Read More
Congratulations Dr. Jeanne Marrazzo
NIH selects Dr. Jeanne Marrazzo as director of the National Institute of Allergy and Infectious Diseases Read More
Babies’ gut microbiome not influenced by mothers’ vaginal microbiome composition
Frontiers Science News features our latest publication, titled “Maternal vaginal microbiome composition does not affect development of the infant gut microbiome in early life”. This study has one of the largest mother-infant cohort studies to date. Read More
COVID-19 vaccination during pregnancy helps protect newborns, Canadian study suggests
CBC News features Dr. Deborah Money, who comments on the benefit of COVID-19 vaccination in pregnancy, explaining that getting vaccinated during pregnancy is also of “great benefit to the infant” after they’re born. Read More
UBC Q & A with Dr. Money
With bivalent COVID-19 boosters rolling out across Canada, Dr. Deborah Money answers questions about what people who are pregnant need to know. Read More
Abstract Submissions for the 13th International Workshop on HIV & Women
The 13th International Workshop on HIV & Women is accepting abstract submissions! Share your research and help shape the unique program for this workshop. The deadline for abstract submission is November 4th, 2022. Read More
Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: A sequential, prospective meta-analysis
Data from our CANCOVID-Preg research project have been part of this prospective meta-analysis published in the American Journal of Obstetrics and Gynecology. August 23, 2022. Read More
Interim Guidance on Monkeypox Exposure for Pregnant People
Drs. Vanessa Poliquin, Andrea Atkinson, Isabelle Boucoiran, Chelsea Elwood, Julie van Schalkwyk, Mark H. Yudin, and Deborah Money released these guidelines on behalf of the SOGC’s Infectious Diseases Committee. June 9th, 2022. Read More
CITF News Release: Omicron Tsunami
Data from our Canadian Antenatal Serosurveillance Study are highlighted in the most recent news release from Canada’s COVID-19 Immunity Task Force (CITF). July 6th, 2022. Read More